Earnings Feed
Start Free
Home/Filings/4/0001415889-15-003713
4//SEC Filing

ACADIA PHARMACEUTICALS INC 4

Accession 0001415889-15-003713

$ACADCIK 0001070494operating
View on SEC.govCompany Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 5:45 PM ET

Size

20.0 KB

Accession

0001415889-15-003713

Insider Transaction Report

Form 4
Period: 2015-11-11
ACADIA PHARMACEUTICALS INCACAD
Iversen Leslie L
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2015-11-11$9.04/sh+6,000$54,240→ 42,127 total
  • Exercise/Conversion

    Common Stock

    2015-11-11$9.04/sh+10,000$90,400→ 52,127 total
  • Exercise/Conversion

    Common Stock

    2015-11-11$9.04/sh+9,126$82,499→ 61,253 total
  • Exercise/Conversion

    Common Stock

    2015-11-11$1.75/sh+4,874$8,530→ 66,127 total
  • Sale

    Common Stock

    2015-11-11$36.01/sh−30,000$1,080,327→ 36,127 total
  • Exercise/Conversion

    Stock option (right to buy)

    2015-11-11−6,000→ 0 total
    Exercise: $9.04Exp: 2016-06-12→ Common Stock (6,000 underlying)
  • Exercise/Conversion

    Stock option (right to buy)

    2015-11-11−10,000→ 0 total
    Exercise: $9.04Exp: 2016-06-12→ Common Stock (10,000 underlying)
  • Exercise/Conversion

    Stock option (right to buy)

    2015-11-11−9,126→ 0 total
    Exercise: $9.04Exp: 2016-06-12→ Common Stock (9,126 underlying)
  • Exercise/Conversion

    Stock option (right to buy)

    2015-11-11−4,874→ 33,697 total
    Exercise: $1.75Exp: 2021-06-09→ Common Stock (4,874 underlying)
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015.
  • [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.67 to $36.44 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
  • [F3]25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the grant date of June 13, 2006.
  • [F4]25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the grant date of June 10, 2011.

Documents

1 file

Issuer

ACADIA PHARMACEUTICALS INC

CIK 0001070494

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001070494

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:45 PM ET
Size
20.0 KB
View on SEC.gov